Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 14, 2020

SELL
$6.03 - $15.24 $75,718 - $191,368
-12,557 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$9.07 - $15.84 $113,891 - $198,902
12,557 New
12,557 $190,000
Q3 2019

Nov 15, 2019

SELL
$9.63 - $14.0 $108,116 - $157,178
-11,227 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$13.4 - $17.67 $150,441 - $198,381
11,227 New
11,227 $166,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.